KalVista Pharmaceuticals Inc News - KALV | ADVFN

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
KalVista Pharmaceuticals Inc (KALV)
KalVista Pharmaceuticals Inc (KALV) News

KalVista Pharmaceuticals Inc (KALV)

8.76

-0.07

(-0.79%)

Closed December 25 4:00PM

Delayed by 15 minutes

8.76

0.00

(0.00%)

After Hours: 5:00PM

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Form 8-K - Current report

KalVista Appoints Jeb Ledell as Chief Operating Officer

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO). Mr...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

–Continuing to build commercial infrastructure; on track for potential sebetralstat launch in Q2 2025– –Multinational regulatory submissions for...

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted five...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Laurence Reid, Ph.D., has been appointed to the Company’s Board of Directors...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

1
Next

Monksdream

Monksdream 6 months ago

KALV 10Q expected July 5

Monksdream

Monksdream 9 months ago

Monksdream

Monksdream 10 months ago

KALV new 52=week high

clydesur

clydesur 11 months ago

INSIDER PURCHASE / SYNDICATE

KALV - 10% OWNER Venrock Healthcare P 86,048 $14.618

Monksdream

Monksdream 11 months ago

KALV new 52 week high

Monksdream

Monksdream 12 months ago

KALV new 52 week high

Femto99

Femto99 4 years ago

I would not even buy the shares at $20.

Femto99

Femto99 4 years ago

Stock_Barber

Stock_Barber 4 years ago

Boom!

Killed it with puts today!

ClayTrader

ClayTrader 4 years ago

* * $KALV Video Chart 02-09-2021 * *

Link to Video - click here to watch the technical chart video

Stock_Barber

Stock_Barber 4 years ago

This company is a disaster...

make it happen

make it happen 4 years ago

The company is delinquent.

make it happen

make it happen 4 years ago

? lol

Profitability
Profit Margin 0.00%
Gross Profit (ttm) $-27.5M
EBITDA $-48.38M
Net Income Avi to Common (ttm) $-37.12M
Diluted EPS (ttm) -2.08

Book Value Per Share (mrq) $3.63

Going to keep diluting more and more

make it happen

make it happen 4 years ago

They are hemorrhaging money. Have pretty much zero revenue. They still have hundreds of millions to spend of your money until phase 3 and beyond.

Operating Margin (ttm) -905.50%

Management Effectiveness

Return on Assets (ttm) -32.60%
Return on Equity (ttm) -45.61%

Revenue $5.4M
Revenue Per Share $0.30

TFMG

TFMG 5 years ago

$KALV Kalvista Pharma Trend Break

Major Downtrend broken
Broken above 200ma
Volume increased
MACD reversed
RSi in bullish uptrend

whytestocks

whytestocks 6 years ago

News: $KALV KalVista Pharmaceuticals Appoints Daniel B. Soland to Board of Directors

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced today that Daniel Soland has been appointed to its Board of Directors effective immediately. Mr...

Find out more https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-appoints-daniel-b-soland-to-board-of-directors-8035190.html

whytestocks

whytestocks 6 years ago

News: $KALV KalVista Pharmaceuticals to Present at Needham Healthcare Conference

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Needham Healthcare Conference on Wednesday, April 10, 2019, a...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-to-present-at-needham-healthcare-conference-7939130.html

stocktrademan

stocktrademan 6 years ago

KALV buy 28.87

normal chart

log chart

whytestocks

whytestocks 6 years ago

News: $KALV KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

– Oral Hereditary Angioedema (HAE) Candidate KVD900 Phase 2 Trial Progressing – – Intravitreal Diabetic Macular Edema (DME) Candidate KVD001 Phase 2 Trial Completion Expected H2 2019 – – Oral Plasma Kallikrein Inhibitor Candidate KVD824 Dosi...

Read the whole news https://marketwirenews.com/news-releases/kalvista-pharmaceuticals-reports-fiscal-third-quarter-results-7846828.html

countryrapper2000

countryrapper2000 7 years ago

Where is everyone?

TheFinalCD

TheFinalCD 7 years ago

$17.85 !!

KALV

Lone Wolf

Lone Wolf 7 years ago

Sniffer rocket ship today!! Wheeee.

KALV

TheFinalCD

TheFinalCD 7 years ago

$15.50 now ~ keep rollin

$KALV

kondziu

kondziu 8 years ago

http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmaceuticals-sells-raptor-pharmaceutical-cm744623

Warchest

Warchest 8 years ago

$8.25 now ~ keep rollin

ming1234

ming1234 8 years ago

any positive news and volume will move this north

Warchest

Warchest 8 years ago

LIVE action starting !!!

Warchest

Warchest 8 years ago

watching close ~

Toxic Avenger

Toxic Avenger 8 years ago

The way this is dropping, there has to be a lawsuit over the sale of cash at 60% off.
Where are those ambulance chasing securities lawyers?

MSparks6

MSparks6 8 years ago

So when will CBYL holders be issued KALV common stock?

Toxic Avenger

Toxic Avenger 8 years ago

CBYL is now KALV with a 1:14 reverse stock split.

Be very careful for the next few days as until all or most of the CBYL shares are converted to KALV, the only sellers will be private Kal Vista investors, those who bought after the symbol change and professionals. The price is likely to be high until existing CBYL retail holders can sell their shares. In addition, the existing CBYL shares will only represent 20% of the O/S. 80% will be held by the private investors in KVAL.

Iam_in

Iam_in 8 years ago

Iam_in

Iam_in 8 years ago

New Ticker symbol now: KALV

Iam_in

Iam_in 8 years ago

Correction : $5.49 PM

Iam_in

Iam_in 8 years ago

WOW - look at this $0,89---> $4,60

New Ticker name now : KALV

look at NASDAQ - PM

Toxic Avenger

Toxic Avenger 8 years ago

Apparently the merger deal was approved by a huge margin.

Still don't get it.

ClayTrader

ClayTrader 8 years ago

* * $CBYL Video Chart 11-21-16 * *

Link to Video - click here to watch the technical chart video

beginneer

beginneer 8 years ago

Attempting to break 0.72. GL to holders

beginneer

beginneer 8 years ago

We'll see how this goes. Hopefully back to over a dollar.

Toxic Avenger

Toxic Avenger 8 years ago

CBYL continuing its upward momentum pre-market.

ClayTrader

ClayTrader 8 years ago

* * $CBYL Video Chart 11-18-16 * *

Link to Video - click here to watch the technical chart video

beginneer

beginneer 8 years ago

Oh okay. Im still up for it even if it is a merger. Good thing volume picked up today.

Toxic Avenger

Toxic Avenger 8 years ago

New buyer? They're not being bought, they're merging with another company and selling their cash at a steep discount.

Maybe the large shareholders decided it's better to take a smaller loss now by liquidating, than wait for a larger loss later and they're voting against the deal.

I can only hope!

beginneer

beginneer 8 years ago

Somethings fishy going on here. Why the sudden spike in volume? New buyer in sight?

Toxic Avenger

Toxic Avenger 8 years ago

Fun while it lasted.

Toxic Avenger

Toxic Avenger 8 years ago

Big bounce today. Anyone know why?

Toxic Avenger

Toxic Avenger 8 years ago

$700k / month for a company that has only a few execs and no business left???

No wonder they want to merge. If they liquidate, the execs all lose their gravy train.

Maybe that can be part of the class action suit.

Toxic Avenger

Toxic Avenger 8 years ago

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

Toxic Avenger

Toxic Avenger 8 years ago

Looks like an attempt to prevent the merger by some shareholders has failed. http://ih.advfn.com/p.php?pid=nmona&article=72839538&symbol=CBYL

Toxic Avenger

Toxic Avenger 8 years ago

Sadly, I don't think so.

KalVista Pharmaceuticals

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions